-
This federal program was meant to help vulnerable patients. But is it leaving them behind?
Learn more about how billions of dollars meant to improve patient care isn’t reaching those most in need. (Partner Content)
-
Addressing health inequities: Biopharmaceutical companies are rising to the occasion
Dr. Lewis-Hall’s personal experiences are paving the way for increased equity for the biopharmaceutical industry. (Partner Content)